Follow
ANAMIKA DHYANI
ANAMIKA DHYANI
Unknown affiliation
No verified email - Homepage
Title
Cited by
Cited by
Year
Analysis of IgE binding proteins of mesquite (Prosopis juliflora) pollen and cross-reactivity with predominant tree pollens
A Dhyani, N Arora, SN Gaur, VK Jain, S Sridhara, BP Singh
Immunobiology 211 (9), 733-740, 2006
462006
Cytomegalovirus and Epstein-Barr infections: prevalence and impact on patients with hematological diseases
J de Melo Silva, R Pinheiro-Silva, A Dhyani, GS Pontes
BioMed research international 2020, 2020
392020
ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells
A Dhyani, A Duarte, J Machado-Neto, S Saad
FEBS Letters 586 (24), 4311–4318, 2012
342012
ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth
A Dhyani, JA Machado-Neto, P Favaro, STO Saad
European journal of cancer 51 (2), 252-259, 2015
262015
Immunoglobulin E (IgE)-mediated cross-reactivity between mesquite pollen proteins and lima bean, an edible legume
A Dhyani, N Arora, VK Jain, S Sridhara, BP Singh
Clinical & Experimental Immunology 149 (3), 517-524, 2007
232007
Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon
P Cesar, A Dhyani, LA Schwade, P Acordi, CX Albuquerque, R Nina, ...
Hematology/Oncology and Stem Cell Therapy 12 (4), 204-210, 2019
182019
Anticancer and immunomodulatory activities of a novel water-soluble derivative of ellipticine
R Costa de Oliveira, G Soares Pontes, A Kostyuk, GB Coutinho Camargo, ...
Molecules 25 (9), 2130, 2020
162020
A clinically relevant major cross‐reactive allergen from mesquite tree pollen
A Dhyani, BP Singh, N Arora, VK Jain, S Sridhara
European journal of clinical investigation 38 (10), 774-781, 2008
162008
Impact of Duffy polymorphisms on parasite density in Brazilian Amazonian patients infected by Plasmodium vivax
RK Abou-Ali, A Dhyani, AL Terço, DM Toro, KS Gomes, LC Tezza, ...
Malaria Journal 18, 1-9, 2019
62019
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells
A Dhyani, P Favaro, STO Saad
Blood Cells, Molecules, and Diseases 84, 102460, 2020
42020
Molecular Characterization of Chryseobacterium indologenes with Multidrug Resistance in the Brazilian Amazon Region
EA Freitas, WA Ferreira, RAAB Filho, CMC Oliveira, A Dhyani, LM Silva, ...
Microbial Drug Resistance 25 (5), 781-786, 2019
22019
ANKHD1 Is Essential for Repair of DNA Double-Strand Breaks in Multiple Myeloma
A Dhyani, P Favaro, STO Saad
Blood 126 (23), 1762, 2015
12015
Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7’, 8’-Dimethoxy-1’, 3’-dimethyl-1, 2, 3’, 4 …
CE de Castro Alves, SL Bogza, N Bohdan, AB Rozhenko, ...
Investigational New Drugs 41 (5), 629-637, 2023
2023
ANKHD1 Is Required for S Phase Progression and Histone Gene Transcription in Multiple Myeloma
A Dhyani, P Favro, STO Saad
Blood 124 (21), 2002, 2014
2014
ANKHD1 Silencing Reduces In Vitro Clonogenicity and In Vivo Tumorogenicity Of Multiple Myeloma Cells
A Dhyani, JA Machado-Neto, P Favaro, STO Saad
Blood 122 (21), 3168, 2013
2013
ANKHD1 Silencing Induces S-Phase Arrest and Modulates Cell Cycle Gene Expression in Human Myeloma Cells
A Dhyani, ASS Duarte, P Favaro, STO Saad
Blood 118 (21), 1828, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–16